United Therapeutics Corporation logo UTHR - United Therapeutics Corporation

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 17
HOLD 12
SELL 1
STRONG
SELL 0
| PRICE TARGET: $635.20 DETAILS
HIGH: $735.00
LOW: $516.00
MEDIAN: $625.00
CONSENSUS: $635.20
UPSIDE: 21.31%

Profitability Ratios

Ratio Value
GP Margin 87.9%
EBIT Margin 54.5%
EBITDA Margin 57.2%
Operating Margin 47.7%
Pretax Margin 53.9%
Cont. Ops Margin 41.9%
Net Margin 41.9%
Bottom Line Margin 41.9%

Liquidity Ratios

Ratio Value
Current Ratio 6.60
Quick Ratio 6.28
Solvency Ratio 1.812
Cash Ratio 2.78

Valuation Ratios

Ratio Value
Price/Earnings
16.17
Hist. avg: 27.9
Peers avg: 25.0
PEG Ratio 1.16
Forward PEG 1.16
Price/Book 3.04
Price/Sales 6.78
Price/FCF 20.74
Price/Op Cash Flow 13.83

Debt Ratios

Ratio Value
Debt/Assets 0.0048
Debt/Equity 0.0053
Debt/Capital 0.0053
Long-Term Debt/Capital 0.0000
Financial Leverage 1.11

Cash Flow Ratios

Ratio Value
Working Capital Turnover 1.01
Operating Cash Flow Ratio 2.785
Operating Cash Flow/Sales 49.1%
Free Cash Flow/Operating Cash Flow 66.7%

Coverage Ratios

Ratio Value
Debt Service Coverage 73.84
Interest Coverage 77.8051
Short-Term Operating Cash Flow Coverage 0.00
Operating Cash Flow Coverage 41.52
Capital Expenditure Coverage 3.00
Dividend + Capital Expenditure Coverage 3.00

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 71.84
EPS 30.129
Debt/Share 1.2889
Cash/Share 35.15
Book Value/Share 160.19
Tangible BV/Share 157.56
Equity/Share 160.19
Operating Cash Flow/Share 35.242
Capital Expenditure/Share 11.749
FCF/Share 23.492

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 0.779
Earnings Before Tax/EBIT 1.130
Price/Fair Value 3.04
Debt/Market Cap 0.0000
Effective Tax Rate 22.1%
Enterprise Value Multiple 11.03